Telemus Capital LLC Sells 1,213 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Telemus Capital LLC lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 10.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,960 shares of the pharmacy operator’s stock after selling 1,213 shares during the period. Telemus Capital LLC’s holdings in Walgreens Boots Alliance were worth $286,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Highlander Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $26,000. Venturi Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Walgreens Boots Alliance by 308.4% during the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 845 shares during the last quarter. Rocky Mountain Advisers LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $30,000. Finally, Planned Solutions Inc. bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $34,000. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on WBA shares. UBS Group cut their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Deutsche Bank Aktiengesellschaft cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, April 3rd. Bank of America cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Finally, SVB Leerink cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research note on Monday, March 18th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $24.36.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction that occurred on Monday, January 29th. The stock was acquired at an average cost of $22.44 per share, with a total value of $99,992.64. Following the transaction, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders have bought a total of 13,456 shares of company stock worth $270,423 in the last ninety days. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $18.22 on Tuesday. Walgreens Boots Alliance, Inc. has a 12-month low of $17.51 and a 12-month high of $35.54. The business’s fifty day moving average is $20.33 and its 200 day moving average is $21.89. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The stock has a market cap of $15.72 billion, a P/E ratio of -2.60, a P/E/G ratio of 1.13 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same period last year, the business earned $1.16 EPS. Walgreens Boots Alliance’s quarterly revenue was up 6.3% compared to the same quarter last year. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.